about
sameAs
Multiple endocrine neoplasia type 2Familial syndromes associated with neuroendocrine tumoursRAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumorsIdentification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples.Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform.RET PLCγ phosphotyrosine binding domain regulates Ca2+ signaling and neocortical neuronal migration.Solid tumors associated with multiple endocrine neoplasias.Gas1 is related to the glial cell-derived neurotrophic factor family receptors alpha and regulates Ret signaling.The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.Modelling melanoma in mice.Inflammation in thyroid oncogenesis.RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways.Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC.Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec.Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies.
P2860
Q21203027-BC8E6FA1-2366-405C-B789-837741D2DCE4Q26777791-29CB668B-35E8-496C-A24E-A639DECA55EDQ28254955-967007C4-821C-4006-855F-2E4A08B30A49Q28830947-A131ABD8-9279-4D1F-AC65-0A14B40FD85FQ33393498-5DBB84CA-392E-4588-AF47-C239F94FAA97Q34097428-E5689CCA-CC14-4D24-B6B4-34AF1CD4B4BFQ34166301-34400F63-2EB2-4F15-A7C7-525663C51603Q34213017-0BA1EB9E-AEE1-4E2D-BC42-9D2C52BFCD2BQ34503991-98FD2F40-A83E-4B14-AB9A-F7B5635ADDECQ36450451-9C7BA3B3-A96F-454A-861E-ED33F789402EQ36611016-2B8F93D0-E759-4A6A-864B-E5BD4D6989F2Q37943839-696EE71E-D7A9-4F7B-A944-426FBDDA39DBQ38017194-4D174DA8-8E70-4C2C-85CB-8BC78CCA7930Q38026893-FAD506F1-48A0-4019-B135-EF00A9811738Q39171940-4ABD3283-BFB9-465F-A6B7-F0A7D9C606C6Q39208774-0197A127-B06D-4B87-977F-2DF22AE2D1A9Q40277135-BDD0B6A8-52EA-493E-A601-CD601E9BAD0AQ40956900-5DDFF76B-77DE-426B-8EC0-A00A1EA7ED4DQ45829274-1659583A-1C26-481B-90A6-6F49B55E9C18Q46027369-0A6B332D-3539-4310-A781-2D99B31669C5Q46754712-18DFAF9E-D8DD-437E-A5AA-1ED8B25E4217Q47116289-88F887F8-E885-4FF6-9FE4-268450E836BC
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dysfunction of the RET receptor in human cancer
@ast
Dysfunction of the RET receptor in human cancer
@en
Dysfunction of the RET receptor in human cancer
@nl
type
label
Dysfunction of the RET receptor in human cancer
@ast
Dysfunction of the RET receptor in human cancer
@en
Dysfunction of the RET receptor in human cancer
@nl
altLabel
Oncogenic protein tyrosine kinases
@en
prefLabel
Dysfunction of the RET receptor in human cancer
@ast
Dysfunction of the RET receptor in human cancer
@en
Dysfunction of the RET receptor in human cancer
@nl
P2093
P3181
P1476
Dysfunction of the RET receptor in human cancer
@en
Oncogenic protein tyrosine kinases
@en
P2093
F Carlomagno
F. Carlomagno
M. Santoro
R M Melillo
R. M. Melillo
P2888
P304
P3181
P356
10.1007/S00018-004-4276-8
P407
P577
2004-12-01T00:00:00Z